Topics

Latest "Factors associated with early seizures after surgery unruptured" News Stories

17:00 EST 14th November 2019 | BioPortfolio

Here are the most relevant search results for "Factors associated with early seizures after surgery unruptured" found in our extensive news archives from over 250 global news sources.

More Information about Factors associated with early seizures after surgery unruptured on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Factors associated with early seizures after surgery unruptured for you to read. Along with our medical data and news we also list Factors associated with early seizures after surgery unruptured Clinical Trials, which are updated daily. BioPortfolio also has a large database of Factors associated with early seizures after surgery unruptured Companies for you to search.

Showing "Factors associated with early seizures after surgery unruptured" News Articles 1–25 of 16,000+

Thursday 14th November 2019

Roles of vascular risk factors in the pathogenesis of dementia


Dermira Presents New Scientific Research Findings from the Lebrikizumab Program at Leading International Itch Conference

- New findings in human sensory neurons highlight role of IL-13 in amplifying itch and lebrikizumab’s role in inhibiting itch signals in atopic dermatitis - Lebrikizumab Phase 3 program is currently enrolling adult and adolescent patients with moderate-to-severe atopic dermatitis Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical derm...

Second Sight Reports Third Quarter 2019 Financial Results

-- Reached agreement with FDA regarding the primary efficacy endpoint for the Orion pivotal trial -- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today reported financial results for the th...


Tricida Announces FDA Acceptance of New Drug Application for Veverimer

Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today that the U.S. Food and Drug Administration (FDA) has accepted for review its New Drug Application (NDA) for ...

Aurinia Reports Third Quarter 2019 Financial Results and Recent Operational Highlights

- Conference call and webcast to be hosted today at 4:30pm EDT – Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today reported financial results for the three and nine months ended September 30, 2019 and recent operational highlights. Amounts, u...

Axonics® Announces Third Quarter 2019 Financial Results and Operational Update

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, reported today financial results for the third quarter ended September 30, 2019, and provided an update on operational initiatives. Recent Business Highlights ...

Global Endpoint Security Market Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing Forecasts to 2025 [Report Updated: 06042019] Prices from USD $4499

The Global Endpoint Security Market is expected to grow from USD 6479.65 Millions in 2018 to USD 20871.56 Millions by the end of 2025 at a Compound Annual Growth Rate CAGR of 18.18%.Increasing need to protect endpoints is one of the factors largely attributing to the growth of Global Endpoint Security Market The factors attributing to the growth of the market are Comprehensive, easytomanage, multi...

Danbury Hospital Researchers On Track Developing Tool For More Precise Diagnosis Of Gynecologic Cancers

A promising new non-invasive diagnostic tool designed to detect women’s cancers, even at the earliest stages of disease development or their recurrence, is attracting interest and attention. DANBURY, Conn. (PRWEB) November 14, 2019 A promising new non-invasive diagnostic tool designed to detect women’s cancers, even at the earliest stages of disease development or their recurrence, is attract...

Children's Tumor Foundation Announces FDA Accepts Submission for Selumetinib as Treatment for Neurofibromatosis and Grants Priority Review

Would Become First Approved Drug for Genetic Disorder Affecting Millions. NEW YORK (PRWEB) November 14, 2019 AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis...

NIH adds five Lasker Clinical Research Scholars

Exceptional early stage scientists mark NIH’s commitment to build the next generation of biomedical researchers.

Enamel proteome shows that Gigantopithecus was an early diverging pongine

Nash Family Dentistry Provides Stable Dentures to Jackson, MS with Implant Supported Dentures

The respected dentists at Nash Family Dentistry offer Vicksburg and Jackson, MS patients implant supported dentures to secure their loose or ill-fitting dentures. Implant supported dentures allow patients with missing teeth to regain up to 90 percent of their natural chewing and biting power, while feeling more confident in the stability of their prosthetic teeth. Jackson, MS (PRWEB) November 14, ...

ReShape Lifesciences Announces Third Quarter 2019 Financial Results

SAN CLEMENTE, CA / ACCESSWIRE / November 14, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, today reported financial results for the three months ended September 30, 2019. Recent Highlights and Accomplishments Recognized revenue of $3.5 million in the third quarter of 2019 Fully ...

The choice of analysis of variance models in repeated measurements analysis—on the effect of glaucoma surgery on retinal structures

Best surgery for long-term weight loss not yet clear

(Reuters Health) - People with obesity may initially shed more excess pounds with an older operation known as Roux-en-Y gastric bypass than with a newer sleeve gastrectomy procedure, but a research review suggests that longer-term, which one is bette...

Clinical Review Demonstrates Cost-Effectiveness of Impella in High-Risk PCI and Cardiogenic Shock

To mark the five year anniversary of the study by Stretch, et al., on cost and outcomes trends for short-term mechanical circulatory support, Abiomed announces a comprehensive publication review of cost and comparative effectiveness of Impella in high-risk PCI and c

Prognostic Biomarker Test Identifies High-Risk Sepsis in Kids

A rapid blood assay accurately classifies risk according to severity and suggests higher-dose antibiotics should be an early option for patients with severe sepsis whose outlook is poor, new data show. Medscape Medical News

Prognostic Biomarker Test Predicts High-Risk Sepsis in Kids

A rapid blood assay accurately classifies risk according to severity and suggests higher-dose antibiotics should be an early option for patients with severe sepsis whose outlook is poor, new data show. Medscape Medical News

SunLink Health Systems, Inc. Announces Fiscal 2020 First Quarter Results

SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $143,000 (a loss of $0.02 per fully diluted share) for its first fiscal quarter ended September 30, 2019 compared to a loss of $786,000, (a loss of $0.11 per fully diluted share) for the quarter ended September 30, 2018. Net loss for the quarter ended September 30, 2019 was $261,000 (a loss of $...

New Research Shows Benefits of Exactech Knee and Shoulder Joint Replacement Innovations

Scientific Studies Featured at International Society for Technology in Arthroplasty Annual Meeting Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery, presented the results of ten new research studies highlighting the benefits of its knee and shoulder implants and supporting technology recently at the 2019 I...

Carisk Partners’ Chief Technology Officer Allen Spokane Elected President of 2019-2020 Executive Committee for Society for Information Management - New Jersey

Carisk Partners (Carisk), a specialty risk transfer and care coordination company, is pleased to announce that Allen Spokane, chief technology officer, Carisk, has been elected as president of the 2019-2020 Executive Committee for the

Aspen Dental Makes Access to Comprehensive Care Easier in Evergreen Park, IL

Aspen Dental is expanding access to care in the Evergreen Park, IL community with a new office opening on Thurs., Nov. 21. The new office, at 9521 S. Western Ave., has convenient parking and features many amenities designed to make a patient’s visit as easy and comfortable as possible. In addition, the office is open extended hours on weekdays and

Apple Launches Three Innovative Studies Today in the New Research App

The Apple Heart and Movement, Women’s Health and Hearing Studies Now Open for Enrollment Apple® today announced that customers in the US can enroll in three landmark health studies — the Apple Women’s Health Study, the Apple Heart and Movement Study, and the Apple Hearing Study. Conducted in partnership with leading academic and research institutions, these multi-year longitudinal studies...

ICON plc to Present at Jefferies 2019 London Healthcare Conference

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at Jefferies 2019 London Healthcare Conference on Thursday, November 21, 2019. The presentation will be webcast live from 1.20pm GMT. A link to the live...

Varex to Highlight Advanced Imaging Components at Medica in Dusseldorf

Varex at Medica 2019: Hall 10 Booth #E11 November 18-21, 2019 Venue: Messe Dusseldorf Am Staad, 40474 Düsseldorf, Germany Varex Imaging Corporation (Nasdaq: VREX) today announced it will showcase its digital detectors, X-ray imaging tubes, connect and control devices and software solutions at Medica 2019. Medica is attended by leaders in the fields of business and research, and international ex...


Quick Search

News Quicklinks